Schoellerbank Global Health Care: Key figures & conditions

Price graphic per 18/10/19

Schoellerbank Global Health Care
(before 19/06/2009 All Pharma)

Fund type: Fund of funds Investment principle: Invests exclusively in equity funds with a focus on pharmaceutical/healthcare shares. Selection of funds in accordance with the Schoellerbank fund rating. Funds with different investment styles are put together (multi-manager approach). This reduces the risk while at the same time optimising earnings for fund of funds. Investment aim: Long-term high level value growth Investment horizon: Long-term Currency: EUR Risk of loss: high Fund management: Schoellerbank Invest AG

ISIN: AT0000721501
Fund volume: EUR 7.44 Mio. (30/08/2019)
Information: launch date: 04/01/2001; first issue price: EUR 10.50; financial year: 01/07 - 30/06.; date of dividend: reinvestment; no dividends; date of payment: 1. bank working-day in September
Account deadline: issue / redemption price on the next stock exchange business day after the next
Conditions: issue surcharge: 5%; management fee: 1.5% p.a. (included in fund price)
Other information:registered for sale in Germany
Note: 19/06/2009: change of name from All Pharma to Schoellerbank Global Health Care

Advertising notice. The Fund Regulations of Schoellerbank Global Health Care are approved by the Austrian Financial Market Authority (Finanzmarktaufsicht) and became effective on 13th September 2012. The Schoellerbank Global Health Care can invest up to 100% of the fund’s assets in other funds. Owing to the composition of the portfolio the investment fund exhibits increased volatility. The most recent version of the prospectus published for Schoellerbank Global Health Care and the key investor information in German are available free of charge at These are the only advertising materials and contain important risk warnings. Although the information has been compiled with utmost care, no liability is assumed for the correctness.